Valois Drug Delivery 2007

We have collected information about Valois Drug Delivery 2007 for you. Follow the links to find out details on Valois Drug Delivery 2007.


Valois valve in insulin device - In-PharmaTechnologist

    https://www.outsourcing-pharma.com/Article/2007/02/13/Valois-valve-in-insulin-device
    Feb 13, 2007 · The patented large dose metering valve developed by Valois will be used in the inhaler device for the delivery of Generex' Oral-Lyn (liquid human insulin), an oral insulin spray for the treatment of …

VALOIS Pharmaceutical Division

    http://wwwtest.valois.com/pharma/fr/publication/publication.php
    Existing and emerging technologies/markets for Nasal, Pulmonary and Ophtalmic Drug Delivery

CFC-free metering valves boost Valois 2007 income 28 per cent

    https://www.in-pharmatechnologist.com/Article/2008/07/01/CFC-free-metering-valves-boost-Valois-2007-income-28-per-cent
    Industrial spray and aerosol manufacturer Valois says that strong performance in its pharmaceutical division helped it off-set a hike in raw materials costs and have a successful 2007.

VALOIS Pharmaceutical Division

    http://wwwtest.valois.com/pharma/en/presse/presse.php
    Valois Pharma will unveil a new and innovative side-actuated device for nasal drug delivery at the upcoming Nasal Drug Delivery conference, organized by Management Forum and to be held in London on April 1st and 2nd. This easy to use device, ...

Justification of the Request for a Negative Vote on ISO ...

    https://ipacrs.org/assets/uploads/comments/On_ISO_20072_Nov_07.pdf
    experts in response to ISO DIS 20072:2007 Aerosol Drug Delivery Device Design Verification – Requirements and Methods. This paper represents the position of the following companies and institutions, all of which have expertise in the design, development, testing, manufacturing or marketing of

Valois Pharma’s Prohaler® Dry PowDer inhaler secures Dose ...

    http://wwwtest.valois.com/admin/presse/communique/fichier/XG12518175234a9d3833d24bd.pdf
    for world asthma Day, Valois Pharma is unveiling the results of a clinical study with patients suffering from asthma and chronic obstructive pulmonary disease (coPD) using its proprietary Dry Powder inhaler Prohaler®. The dry powder inhaler, an innovative drug delivery device …

Mesoporous Materials for Drug Delivery - Vallet‐Regí ...

    https://onlinelibrary.wiley.com/doi/full/10.1002/anie.200604488
    Sep 28, 2007 · Research on mesoporous materials for biomedical purposes has experienced an outstanding increase during recent years. Since 2001, when MCM‐41 was first proposed as drug‐delivery system, silica‐based materials, such as SBA‐15 or MCM‐48, and some metal–organic frameworks have been discussed as drug carriers and controlled‐release systems.Author: María Vallet-Regí, Francisco Balas, Daniel Arcos

VALOIS Pharmaceutical Division - About us

    http://wwwtest.valois.com/pharma/en/pharmaceutical/about_us.php
    Valois Pharma is a global expert which specializes in Nasal and Pulmonary drug delivery technologies that enhance the administration of drug products. Valois Pharma is the world leading supplier of nasal spray pumps and also the world leading supplier of aerosol metering valves for pMDIs. We offer a broad range of products and services that also applies to other drug delivery routes such as buccal/sub …

Mesoporous silicon in drug delivery applications - Salonen ...

    http://onlinelibrary.wiley.com/doi/10.1002/jps.20999/abstract
    Jan 16, 2008 · Mesoporous silicon has many important properties advantageous to drug delivery applications. The small size of the pores confines the space of a drug and engages the effects of surface interactions of the drug molecules and the pore wall. The size of the pores and the surface chemistry of the pore walls may be easily changed and controlled.

Bacteria-mediated delivery of nanoparticles and cargo into ...

    https://www.nature.com/articles/nnano.2007.149
    Jun 10, 2007 · Liposomal or other encapsulated delivery methods suffer from the problem of entrapment in the subcellular vesicles and the biomolecule's inability to access the cytosol or other intended target ...Author: Demir Akin, Jennifer Sturgis, Kathy Ragheb, Debby Sherman, Kristin Burkholder, J. Paul. Robinson, Ar...

Searching for Valois Drug Delivery 2007?

You can just click the links above. The data is collected for you.

Related Delivery Info